English
Segment disclosures
Company overviewCovidien plc
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Active Pharmaceutical Ingredients · Pharmaceuticals
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:ActivePharmaceuticalIngredientsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 416000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 395000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 405000000 | Unit1 | 20111123 | Open filing evidence |
Airway And Ventilation Products · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:AirwayAndVentilationProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 752000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 770000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 763000000 | Unit1 | 20111123 | Open filing evidence |
Contrast Products · Pharmaceuticals
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:ContrastProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 598000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 604000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 591000000 | Unit1 | 20111123 | Open filing evidence |
Endomechanical Instruments · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:EndomechanicalInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 2342000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 2139000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 1982000000 | Unit1 | 20111123 | Open filing evidence |
Energy Devices · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:EnergyDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 1170000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 992000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 867000000 | Unit1 | 20111123 | Open filing evidence |
Medical Surgical Products · Medical Supplies
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:MedicalSurgicalProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 441000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 412000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 417000000 | Unit1 | 20111123 | Open filing evidence |
Nursing Care Products · Medical Supplies
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:NursingCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 808000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 783000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 790000000 | Unit1 | 20111123 | Open filing evidence |
Original Equipment Manufacturer Products · Medical Supplies
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:OriginalEquipmentManufacturerProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 221000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 208000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 211000000 | Unit1 | 20111123 | Open filing evidence |
Other Products · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:OtherProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 386000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 395000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 432000000 | Unit1 | 20111123 | Open filing evidence |
Oximetry And Monitoring Products · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:OximetryAndMonitoringProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 853000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 755000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 636000000 | Unit1 | 20111123 | Open filing evidence |
Radiopharmaceuticals · Pharmaceuticals
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:RadiopharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 459000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 519000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 556000000 | Unit1 | 20111123 | Open filing evidence |
Sharpsafety Products · Medical Supplies
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:SharpsafetyProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 308000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 320000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 334000000 | Unit1 | 20111123 | Open filing evidence |
Soft Tissue Repair Products · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:SoftTissueRepairProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 900000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 854000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 807000000 | Unit1 | 20111123 | Open filing evidence |
Specialty Pharmaceuticals · Pharmaceuticals
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:SpecialtyPharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 494000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 473000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 544000000 | Unit1 | 20111123 | Open filing evidence |
Vascular Products · Medical Devices
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cov:VascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 1426000000 | Unit1 | 20111123 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 810000000 | Unit1 | 20111123 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 574000000 | Unit1 | 20111123 | Open filing evidence |
Medical Devices · Airway And Ventilation Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:AirwayAndVentilationProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 770000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 763000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 806000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Endomechanical Instruments
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:EndomechanicalInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 2139000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 1982000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 1928000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Energy Devices
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:EnergyDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 992000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 867000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 805000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Other Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OtherProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 395000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 432000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 460000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Oximetry And Monitoring Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OximetryAndMonitoringProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 755000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 636000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 636000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Soft Tissue Repair Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:SoftTissueRepairProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 854000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 807000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 786000000 | USD | 20101122 | Open filing evidence |
Medical Devices · Vascular Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cov:VascularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 810000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 574000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 493000000 | USD | 20101122 | Open filing evidence |
Medical Supplies · Medical Surgical Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSurgicalProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 412000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 417000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 431000000 | USD | 20101122 | Open filing evidence |
Medical Supplies · Nursing Care Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:NursingCareProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 783000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 790000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 784000000 | USD | 20101122 | Open filing evidence |
Medical Supplies · Original Equipment Manufacturer Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:OriginalEquipmentManufacturerProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 208000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 211000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 212000000 | USD | 20101122 | Open filing evidence |
Medical Supplies · Sharpsafety Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:MedicalSuppliesMember;us-gaap:StatementBusinessSegmentsAxis=cov:SharpsafetyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 320000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 334000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 362000000 | USD | 20101122 | Open filing evidence |
Pharmaceuticals · Active Pharmaceutical Ingredients
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:ActivePharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 395000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 405000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 431000000 | USD | 20101122 | Open filing evidence |
Pharmaceuticals · Contrast Products
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:ContrastProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 604000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 591000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 635000000 | USD | 20101122 | Open filing evidence |
Pharmaceuticals · Radiopharmaceuticals
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:RadiopharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 519000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 556000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 559000000 | USD | 20101122 | Open filing evidence |
Pharmaceuticals · Specialty Pharmaceuticals
Segment Reporting Information By Segment · Statement Business Segments
Source dimensions
us-gaap:SegmentReportingInformationBySegmentAxis=cov:PharmaceuticalsMember;us-gaap:StatementBusinessSegmentsAxis=cov:SpecialtyPharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2009-09-26 – 2010-09-24 | 473000000 | USD | 20101122 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 544000000 | USD | 20101122 | Open filing evidence |
| 2007-09-29 – 2008-09-26 | 525000000 | USD | 20101122 | Open filing evidence |
Medical Devices
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cov:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 7829000000 | Unit1 | 20111123 | Open filing evidence |
| 2011-03-26 – 2011-06-24 | 1985000000 | Unit1 | 20110729 | Open filing evidence |
| 2010-09-25 – 2011-06-24 | 5739000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 6715000000 | Unit1 | 20111123 | Open filing evidence |
| 2010-03-27 – 2010-06-25 | 1630000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-06-25 | 4942000000 | Unit1 | 20110729 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 6061000000 | Unit1 | 20111123 | Open filing evidence |
Medical Supplies
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cov:MedicalSuppliesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 1778000000 | Unit1 | 20111123 | Open filing evidence |
| 2011-03-26 – 2011-06-24 | 441000000 | Unit1 | 20110729 | Open filing evidence |
| 2010-09-25 – 2011-06-24 | 1297000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 1723000000 | Unit1 | 20111123 | Open filing evidence |
| 2010-03-27 – 2010-06-25 | 427000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-06-25 | 1291000000 | Unit1 | 20110729 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 1752000000 | Unit1 | 20111123 | Open filing evidence |
Pharmaceuticals
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cov:PharmaceuticalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-09-25 – 2011-09-30 | 1967000000 | Unit1 | 20111123 | Open filing evidence |
| 2011-03-26 – 2011-06-24 | 500000000 | Unit1 | 20110729 | Open filing evidence |
| 2010-09-25 – 2011-06-24 | 1460000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-09-24 | 1991000000 | Unit1 | 20111123 | Open filing evidence |
| 2010-03-27 – 2010-06-25 | 507000000 | Unit1 | 20110729 | Open filing evidence |
| 2009-09-26 – 2010-06-25 | 1526000000 | Unit1 | 20110729 | Open filing evidence |
| 2008-09-27 – 2009-09-25 | 2096000000 | Unit1 | 20111123 | Open filing evidence |